Results for
"[search-keyword]"
Sponsor content
176 result(s) found, displaying 31 to 40
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 15 mg/0.5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 12.5 mg/0.5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 40 mg immediate release capsules.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 80 mg immediate release capsules.
-
Australian Public Assessment Report (AusPAR)Mounjaro (tirzepatide) is approved for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.
-
Prescription medicine decision summaryOmvoh (mirikizumab) is approved to treat moderately to severely active ulcerative colitis.
-
Oct-2023Prescription medicine evaluationActive ingredient: donanemab.
-
Prescription medicine registrationActive ingredients: mirikizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 2.5 mg/0.5 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection pre-filled pen.